Tokyo, Japan

Maki Komamine

This inventor holds 1 USPTO granted patent. Top assignee: Nec Corporation. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maki Komamine: Innovator in Drug Adverse Event Extraction

Introduction

Maki Komamine is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the area of drug safety. His innovative work focuses on methods to improve the extraction of adverse events related to drug use.

Latest Patents

Maki Komamine holds a patent for a "Drug adverse event extraction method and apparatus." This method involves extracting a combination of a drug and an adverse event related to the drug. It includes processing positive and negative example combinations, extracting medical events from patient data, and generating attribute data based on time-series information. The method also involves learning a discriminant model to determine scores for combinations that are neither positive nor negative examples. This patent highlights his commitment to enhancing patient safety through advanced technology.

Career Highlights

Maki Komamine is currently employed at NEC Corporation, where he continues to develop innovative solutions in the medical field. His work at NEC Corporation has allowed him to collaborate with other talented professionals and contribute to significant advancements in healthcare technology.

Collaborations

Some of Maki's coworkers include Yuki Kosaka and Kazuyo Narita, who also play vital roles in their respective projects. Their collaboration fosters a creative environment that encourages innovation and the development of new technologies.

Conclusion

Maki Komamine's contributions to drug safety through his patented methods demonstrate his dedication to improving healthcare outcomes. His work at NEC Corporation and collaborations with talented colleagues further enhance the impact of his innovations in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…